Charles Cherington

Charles Reed Cherington was the founder of Paratus Capital Management, founded in 1999, where the title held was Partner from 1999 to 2004.
Mr. Cherington was the founder of Cherington Capital LLC, founded in 2002, where the title held was Partner from 2002 to 2006.
Mr. Cherington is the founder of Ara Advisers LLC, founded in 2017, where the title held is Managing Partner since 2017.
Mr. Cherington is also the founder of Amberjack Capital Partners LP..
Mr. Cherington is currently Director at The Conservation Fund, Aegis Chemical Solutions LLC, Benchmark Completions LLC, Divert, Inc., Brooklyn Immunotherapeutics Investors LP, Square Robot, Inc., Utility Global, Inc., Px Holdco3 Ltd., and GIDARA Energy BV.
Mr. Cherington is Independent Director at Beard Energy Transition Acquisition Corp.
since 2021.
Mr. Cherington is Manager at Eterna Therapeutics LLC since 2018.
Former positions include Chairman at Ernexa Therapeutics, Inc. from 2021 to 2023, Director at IRX Therapeutics, Inc., Director at Soane Energy LLC, President & Director at FCG Chemical, Inc., Vice President at The Vietnam Fund Ltd., and Principal at CS First Boston Pacific, Inc. Education includes an MBA from The University of Chicago in 1992 and an undergraduate degree from Wesleyan University in 1987.